本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.13
+0.08508.17%
盘后1.130.00000.00%18:13 EDT
成交量:5.75万
成交额:6.22万
市值:1,445.97万
市盈率:-1.04
高:1.13
开:1.07
低:1.05
收:1.04
数据加载中...
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/12

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/07/10

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

超过5%披露

[Amend] General statement of acquisition of beneficial ownership